Literature DB >> 12508305

Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus infection.

Kazuaki Kanai1, Satoshi Kuwabara, Masahiro Mori, Kimihito Arai, Takako Yamamoto, Takamichi Hattori.   

Abstract

We report a patient with leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus (EBV) infection. A 55-year-old man had been suffering from chronic progressive axonal polyneuropathy and skin erythema for 3 years. A skin biopsy showed capillary vasculitis with clustered leukocyte fragments. Findings of serum assays, a polymerase chain reaction for EBV-DNA, and in situ hybridization indicated chronic EBV infection. Immunosuppressive treatment resulted in the gradual lessening of his general and neurologic symptoms.

Entities:  

Mesh：

Year:  2003        PMID： 12508305     DOI： 10.1002/mus.10287

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


  8 in total

1.  Leucocytoclastic vasculitic neuropathy diagnosed by biopsy of normal appearing skin.

Authors:  Y Yamanaka; A Hiraga; K Arai; M Mori; K Kanai; T Hattori; S Kuwabara; T Oide; T Tanizawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

Review 2.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

3.  Epstein-Barr virus-related cutaneous necrotizing vasculitis in a girl heterozygous for factor V Leiden.

Authors:  Cristina Guerriero; Gaia Moretta; Giulia Bersani; Piero Valentini; Antonio Gatto; Donato Rigante
Journal:  J Dermatol Case Rep       Date:  2017-12-01

4.  Anti-neutrophil cytoplasmic antibody-associated vasculitis associated with infectious mononucleosis due to primary Epstein-Barr virus infection: report of three cases.

Authors:  Makoto Yamaguchi; Tomoki Yoshioka; Taishi Yamakawa; Matsuyoshi Maeda; Hideaki Shimizu; Yoshiro Fujita; Shoichi Maruyama; Yasuhiko Ito; Seiichi Matsuo
Journal:  Clin Kidney J       Date:  2013-12-05

Review 5.  Environmental factors influencing the risk of ANCA-associated vasculitis.

Authors:  Wen-Man Zhao; Zhi-Juan Wang; Rui Shi; Yu-Yu Zhu; Sen Zhang; Rui-Feng Wang; De-Guang Wang
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

6.  Therapy for vasculitic neuropathies.

Authors:  Kenneth C Gorson
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

7.  Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights.

Authors:  Paola Marmiroli; Beatrice Riva; Eleonora Pozzi; Elisa Ballarini; Dmitry Lim; Alessia Chiorazzi; Cristina Meregalli; Carla Distasi; Cynthia L Renn; Sara Semperboni; Lavinia Morosi; Federico A Ruffinatti; Massimo Zucchetti; Susan G Dorsey; Guido Cavaletti; Armando Genazzani; Valentina A Carozzi
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

Review 8.  The role of infectious agents in the pathogenesis of vasculitis.

Authors:  Nicolò Pipitone; Carlo Salvarani
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-10       Impact factor: 4.098
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.